Agentix is a biopharmaceutical company that focuses on the development of a suite of health solutions for patients and consumers.

The company also focused on the development of synthetic agonists, inverse agonists, and antagonists that modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help